India has made significant progress in expanding healthcare access through initiatives such as Ayushman Bharat and the regulation of essential medicine prices. However, the pricing of medical services—including consultations, diagnostics, surgeries, and hospital procedures—remains largely unregulated, resulting in substantial cost variations across providers. This fragmented pricing landscape has contributed to high out-of-pocket healthcare expenditure, financial hardship, and limited cost transparency for millions of patients.
The National Medical Pricing and Regulation Commission Bill, 2026 proposes the establishment of a dedicated regulatory authority to standardize healthcare service pricing across the country. By introducing transparent pricing frameworks, monitoring mechanisms, and coordinated Centre-State implementation, the Bill seeks to enhance affordability, strengthen financial protection, and promote greater accountability within India's healthcare system. As India moves towards universal health coverage, this legislation represents a significant policy step in addressing one of the most persistent gaps in healthcare regulation.
Key Highlights
- Healthcare pricing in India remains largely unregulated, with consultations, diagnostics, and procedures following market-driven pricing, resulting in significant cost disparities across providers.
- Private healthcare dominates service delivery, with nearly 70% of healthcare infrastructure concentrated in the private sector in many states, making standardized pricing a critical policy need.
- The National Medical Pricing and Regulation Commission Bill, 2026 proposes India's first comprehensive framework to standardize healthcare service pricing, improve transparency, and strengthen financial protection for patients.
- The Bill has the potential to reduce catastrophic healthcare expenditure and improve affordability, but its success will depend on Centre–State coordination, robust cost benchmarking, and effective implementation.
About The Author
Sagar Gulati
Sagar is an accomplished insights professional with 3.5 years of experience leading end-to-end market research projects across global FMCG portfolios. His background includes roles at NielsenIQ, Reliance, and Kantar, where he managed high-visibility strategic studies for Fortune 500 clients such as Nestlé, Unilever, Johnson & Johnson, and Coca-Cola India.
He brings deep expertise in product testing, brand health measurement, concept validation, and shopper behaviour research, coupled with strong cross-regional experience working with stakeholders across APAC and Europe. Known for his analytical rigor and client-centric approach, Sagar consistently delivers actionable insights that drive brand and business impact.
Sagar holds a B.Pharm degree and is a registered pharmacist with the Haryana Pharmacy Council, and he completed his MBA in Marketing from ICFAI Mumbai.
Know More